Teladoc Health (NYSE:TDOC) Slides After Soft Outlook
Market News

Teladoc Health (NYSE:TDOC) Slides After Soft Outlook

Story Highlights

Teladoc Health slid in pre-market trading after issuing a soft outlook.

Teladoc Health (NYSE: TDOC) slid in pre-market trading on Wednesday after the whole-person virtual care company’s guidance left investors disappointed. In Q4, the company has projected revenues in the range of $658 million to $683 million while net loss is likely to be between $0.33 and $0.23 per share. For reference, analysts had forecast a Q4 loss of $0.18 per share and revenues of $687 million. 

In FY23, Teladoc has forecast revenues between $2.6 billion and $2.63 billion while net loss is likely to range from $1.5 to $1.4 per share.

The company reported third quarter results for the Fiscal Year 2023 where its losses narrowed in Q3 to $0.35 per share as compared to a loss of $0.45 per share in the same period last year while analysts were expecting a loss of $0.37 per share.

The company’s revenues increased 8% year-over-year to $660.2 million as compared to Street estimates of $664.1 million.

What is the Forecast for TDOC Stock?

Analysts are sidelined about TDOC stock with a Hold consensus rating based on three Buys and nine Holds. The average TDOC price target of $26 implies an upside potential of 43.5% at current levels.


Price Change
S&P 500
Dow Jones
Nasdaq 100

Popular Articles